Target intelligence / Profile preview

Combined signaling and metabolic pathways

Molecular classification
Other
01

Overview

Combined signaling and metabolic pathways refer to the integrated biochemical networks that coordinate cellular energy status with growth and survival signals. These pathways involve a bidirectional crosstalk where signaling cascades, such as the PI3K/AKT/mTOR axis, regulate metabolic enzymes, while metabolic intermediates like acetyl-CoA and ATP influence signaling through post-translational modifications (Source: Nature Reviews Molecular Cell Biology, 2020). This coordination is essential for maintaining cellular homeostasis and responding to environmental changes. In many diseases, particularly cancer, these pathways are reprogrammed to prioritize biomass accumulation and rapid proliferation over normal physiological functions (Source: NIH, National Cancer Institute). Similarly, dysregulation of these integrated networks is a primary driver of metabolic disorders such as type 2 diabetes and obesity (Source: Cell, 2017). While not a single molecular target, the key nodes within these pathways are major sites for therapeutic intervention, with drugs like metformin and rapamycin acting to restore balance or inhibit pathological signaling.

Other names
Integrated signaling and metabolic networksMetabolic-signaling crosstalkSignaling-metabolic interactome
02

Mechanism of action

Modulation of key regulatory nodes (e.g., AMPK, mTOR, PI3K) that integrate extracellular signals with intracellular metabolic flux.

03

Biological functions

Signal transductionMetabolismCell proliferationEnergy homeostasisCellular respiration
04

Disease associations

CancerDiabetes mellitusMetabolic syndromeNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Systemic metabolic toxicityHyperglycemia or hypoglycemiaImmunosuppressionGastrointestinal distressBroad off-target effects due to network complexity
06

Interacting drugs

Metformin

4 more in the full profile.

07

Biomarkers

Blood glucose levelsLactate levelsmTOR phosphorylation statusAMP/ATP ratioHIF-1alpha expression

Beyond the preview

Go deeper on Combined signaling and metabolic pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Combined signaling and metabolic pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call